介素35通过招募中性粒细胞来促进肝细胞癌的进展

Wei Gan1, Guo-Qiang Sun2, Jin-Long Huang3

  • 1Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Translational oncology
|January 7, 2026
PubMed
概括

高联素-35 (IL-35) 表达通过影响免疫细胞和血管生成促进肝细胞癌 (HCC) 的进展. 联合抗IL-35和抗PD1疗法显示出对HCC治疗的潜力.